Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)
Definium Therapeutics US, Inc.
LSD Occupancy of the Serotonin 2A Receptor in the Human Brain
Rigshospitalet, Denmark
BMN 110 US Expanded Access Program
BioMarin Pharmaceutical
Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy
Tatiana Aboulafia Brakha
LSD-Perceptual-Choice-Study
University Hospital, Basel, Switzerland
Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects
University Hospital, Basel, Switzerland
Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects
University Hospital, Basel, Switzerland
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Definium Therapeutics US, Inc.
Effects of LSD on Neuroplasticity in Healthy Subjects
University of Fribourg
LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy Subjects
University Hospital, Basel, Switzerland
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
Definium Therapeutics US, Inc.
Effect of Ketanserin After LSD Administration
University Hospital, Basel, Switzerland
Sodium Lactate and Brain Relaxation (LSD)
Centre Hospitalier Universitaire de Besancon
LSD Therapy for Persons Suffering From Major Depression
University Hospital, Basel, Switzerland
Stem Cell Gene Therapy for Cystinosis
University of California, San Diego
Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)
University Hospital, Basel, Switzerland
LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
University Hospital, Basel, Switzerland
Brain Derived Neurotropic Factor Response to Aerobic Exercise Intensity in Depressive Patients.
St. Olavs Hospital
A Dose-Ranging Study of 50 µg to 100 µg LSD in Healthy Volunteers
Eleusis Therapeutics
A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
ZevraDenmark
A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years
Eleusis Therapeutics
The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers
Psychiatric University Hospital, Zurich
Neuronal Correlates of Altered States of Consciousness
University Hospital, Basel, Switzerland
A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers
Amicus Therapeutics
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
Shire
Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled Study
University Hospital, Basel, Switzerland
Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)
BioMarin Pharmaceutical
Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
BioMarin Pharmaceutical
A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
BioMarin Pharmaceutical
Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA Patients
Shire
A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA
BioMarin Pharmaceutical
Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety
Multidisciplinary Association for Psychedelic Studies
Shortened LSD Intervention for Major Depressive Disorder
Johns Hopkins University
Microdosing LSD in Women With Premenstrual Disorders
Friederike Holze
LSD Treatment for Persons With Alcohol Use Disorder
Felix Mueller
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
University Hospital, Basel, Switzerland
Drug Effects on Mood and Behavior - Expectancy
University of Chicago
Mood Effects of Serotonin Agonists: Depression
University of Chicago
LSD to Improve Cluster Headache Impact Trial
Radboud University Medical Center
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Definium Therapeutics US, Inc.
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
Definium Therapeutics US, Inc.
Lysergic Acid Diethylamide (LSD) in Palliative Care
University Hospital, Basel, Switzerland
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache
University Hospital, Basel, Switzerland
Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation
BioMarin Pharmaceutical
Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome
BioMarin Pharmaceutical
Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
Shire
A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
BioMarin Pharmaceutical
A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)
BioMarin Pharmaceutical
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.